MXCT News and Press, MaxCyte Inc. From 08/09/22

RGAIA Investment Advisors are an independent, fee-only investment management firm providing wealth management and financial planning for individuals, families, non-profit firms, and corporations of all sizes. Given any recession is bound to be of the traditional variety, there will no...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended June 30, 2022, Baron Health Care Fund declined 10.00% compared with the Benchmark. We are partic...

GAITHERSBURG, Md., July 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, d...

MaxCyte ( NASDAQ: MXCT ) has announced the signing of a strategic platform license with LG Chem, aiming to create new value for its customers based on science. Under the terms, LG Chem obtains non-exclusive clinical and commercial rights to use MaxCyte’s Flow Electr...

GAITHERSBURG, Md., July 12, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, d...

BAMCO’s 13F portfolio value decreased from $47.14B to $40.75B this quarter. Ron Baron increased Spotify and Shopify while reducing Alphabet and Amazon.com. Their top five positions are at ~29% of the overall portfolio. For further details see: Tracking Ron Baron's...

Image source: The Motley Fool. MaxCyte, Inc. (NASDAQ: MXCT) Q1 2022 Earnings Call May 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: MaxCyte, Inc. (MXCT) Q1 2022 Earnings Call Transcript

MaxCyte, Inc. (MXCT) Q1 2022 Earnings Conference Call May 9, 2022, 4:30 PM ET Company Participants Doug Doerfler – President and Chief Executive Officer Amanda Murphy – Chief Financial Officer Sean Menarguez – Investor Relations Conference Call Participants Stephanie Iann...

MaxCyte press release (NASDAQ:MXCT): Q1 GAAP EPS of -$0.04 beats by $0.03. Revenue of $11.6M (+78.5% Y/Y) beats by $3.1M. For further details see: MaxCyte GAAP EPS of -$0.04 beats by $0.03, revenue of $11.6M beats by $3.1M

GAITHERSBURG, Md., May 09, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, de...